EMA Authorised: Duloxetine Viatris (previously Duloxetine Mylan) (duloxetine) — Viatris Limited

View source ↗

Summary

The European Medicines Agency authorised a duloxetine product marketed as Duloxetine Viatris by Viatris Limited for several indications including neuralgia, dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Diabetic Neuropathy
• Major Depressive Disorder
• Neuralgia

Drugs mentioned

• Duloxetine Viatris (duloxetine)

Snippet

Status: Authorised. Therapeutic area: Neuralgia;Diabetic Neuropathies;Depressive Disorder, Major;Anxiety Disorders. MAH: Viatris Limited. Decision date: 10/10/2025